Top 10 Medical Devices markets in CanadaThe fastest-growing and largest of the 26 sized Medical Devices markets in Canada, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Anesthesia Monitoring Devices | $211 Mn | $686 Mn | 12.5% | 24 |
| 2 | Aesthetic Lasers and Energy Devices | $130 Mn | $406 Mn | 12.1% | 28 |
| 3 | Insulin Patch Pumps | $71 Mn | $221 Mn | 12% | 2 |
| 4 | Dental Caries Detectors | $30 Mn | $90 Mn | 11.8% | 2 |
| 5 | Anesthesia & Respiratory Devices | $2.3 Bn | $5.7 Bn | 9.5% | 39 |
| 6 | Air Ambulance Life Support Solutions | $358 Mn | $854 Mn | 9.1% | 2 |
| 7 | Anti-Snoring Devices | $100 Mn | $232 Mn | 8.8% | 20 |
| 8 | Advanced Bipolar Direct Energy Devices | $248 Mn | $571 Mn | 8.7% | 50 |
| 9 | Acute Care Needleless Connectors | $39 Mn | $81 Mn | 7.5% | 0 |
| 10 | Disposable Surgical Devices | $723 Mn | $1.5 Bn | 7.3% | 1,048 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Diabetes Care Devices | $3.4 Bn | $6 Bn | 5.9% | 60 |
| 2 | Anesthesia & Respiratory Devices | $2.3 Bn | $5.7 Bn | 9.5% | 39 |
| 3 | Rehabilitation Equipments | $1.6 Bn | $2.9 Bn | 6.1% | 99 |
| 4 | Defibrillator | $1.4 Bn | $2.5 Bn | 5.9% | 50 |
| 5 | Insulin Delivery Devices | $1.3 Bn | $2.4 Bn | 6.5% | 27 |
| 6 | Angiography Devices | $996 Mn | $1.8 Bn | 6.3% | 75 |
| 7 | Dental Diagnostic and Surgical Equipments | $958 Mn | $1.9 Bn | 7.1% | 312 |
| 8 | Direct Energy Medical Devices | $883 Mn | $1.4 Bn | 5% | 65 |
| 9 | Disposable Surgical Devices | $723 Mn | $1.5 Bn | 7.3% | 1,048 |
| 10 | Audiology Devices | $626 Mn | $1.2 Bn | 6.4% | 15 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Anesthesia Monitoring Devices grows fastest, at 12.5% a year from 2023 to 2033, ahead of Aesthetic Lasers and Energy Devices (12.1%).
Diabetes Care Devices is the largest, worth about $3.4 Bn in 2023 and $6 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
US